Introduction Welcome to the UCB Newsroom, your source for the latest updates, press releases, and stories that showcase our commitment to advancing science and improving patient lives.Stay informed about our recent breakthroughs, partnerships, and innovations through our features and news updates. Latest press releases The press releases are intended for media and financial analysts Press release 5 Jun 2026 New EULAR 2026 data show CIMZIA[®] (certolizumab pegol) delivered consistent effect in rheumatoid... Read More Press release 4 Jun 2026 EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control... Read More Press release 3 Jun 2026 BIMZELX[®](bimekizumab) data at EULAR 2026 show early and sustained inflammation control can improve... Read More Interested in more? Access our media image selection or contact us for particular requests.The UCB media relations team responds to calls and emails from professional journalists only. View all downloadable resources Contact us
Press release 5 Jun 2026 New EULAR 2026 data show CIMZIA[®] (certolizumab pegol) delivered consistent effect in rheumatoid... Read More
Press release 4 Jun 2026 EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control... Read More
Press release 3 Jun 2026 BIMZELX[®](bimekizumab) data at EULAR 2026 show early and sustained inflammation control can improve... Read More
